Keyphrases
Confidence Interval
98%
Men Who Have Sex with Men
88%
United States
86%
New Jersey
75%
San Francisco
47%
Odds Ratio
45%
During Pregnancy
33%
Breast Cancer
28%
Risk Factors
28%
Preterm Birth
27%
Phthalates
26%
Phthalate Exposure
26%
Pregnant Women
25%
Respondent-driven Sampling
24%
AIDS/HIV
23%
Race-ethnicity
21%
Population-based Study
21%
Antiretroviral Therapy
21%
HIV Infection
21%
Birth Weight
21%
HIV Testing
20%
Environmental Influences on Child Health Outcomes
20%
White People
20%
People Who Inject Drugs
19%
Asthma
19%
Mozambique
18%
Adverse Pregnancy Outcomes
18%
Sexual Behavior
18%
Prostate Cancer
18%
HIV Prevalence
18%
Prenatal Exposure
18%
Gestational Age
18%
Black Women
16%
Localized Prostate Cancer
16%
Phthalate Metabolites
16%
Racial Disparities
16%
National HIV Behavioral Surveillance
16%
China
15%
Low Birth Weight
15%
Risk Behavior
15%
High Risk
15%
Surveillance Epidemiology
15%
Anogenital Distance
15%
Hazard Ratio
15%
Infant Development
15%
Blood Lead Level
15%
First Trimester
14%
Socioeconomic Status
14%
Unprotected Sex
14%
Hispanic
14%
HIV-positive
13%
Pre-exposure Prophylaxis (PrEP)
13%
Stillbirth
13%
Canada
13%
Non-Hispanic White
13%
Hawaii
13%
Adjusted Odds Ratio
13%
People of Color
13%
Breast Cancer Risk
13%
Environment Studies
12%
Cancer Incidence
12%
Neonate
12%
African American
12%
HIV Status
12%
Pregnancy Cohort
12%
Multivariable
12%
Meta-analysis
11%
HIV Risk
11%
People Living with HIV (PLHIV)
11%
Population-based
11%
Female Sex Workers
11%
COVID-19
11%
Colorectal Cancer
11%
Relative Risk
11%
Sex Steroid Hormones
11%
Neonatal Mortality
10%
Comorbidity
10%
Lead Dust
10%
Concord
10%
White Women
10%
Infant Mortality
10%
Firefighters
10%
Older Adults
10%
Non-associated
10%
Health Outcomes
10%
HIV-negative
10%
Polyfluoroalkyl Substances
9%
In Cancer
9%
US Cities
9%
Surveillance System
9%
Trimester
9%
Children's Health
9%
Polycyclic Aromatic Hydrocarbons
9%
HIV Prevention
9%
Urinary Phthalate Metabolites
9%
Demographic Characteristics
9%
Carpet
9%
Effect Modification
9%
Cancer Survivors
9%
Breast Cancer Mortality
9%
Coronary Artery Disease
9%
Di-(2-ethylhexyl) Phthalate
9%
Cancer Registry
9%
Time-location Sampling
9%
Postmenopausal Women
9%
Tumor
9%
Breast Cancer Survivors
9%
Black Men
8%
Chemical Exposure
8%
Body Mass Index
8%
Latino
8%
Singleton Pregnancy
8%
Birth Outcomes
8%
Pregnancy Outcome
8%
African American Women
8%
COVID-19 Pandemic
8%
Japanese Workers
8%
Metabolite Concentrations
8%
Pregnancy Cohort Study
8%
Preterm Delivery
8%
Comparative Effectiveness Analysis
8%
Third Trimester
8%
Early Breast Cancer
8%
Diabetes
8%
Racial Differences
8%
Census Tract
8%
Incidence Rate
8%
Stressful Life Events
8%
Condom Use
8%
House Dust
8%
Childhood Asthma
8%
Group B Streptococcus
8%
Children Living with HIV
8%
DNA Methylation (DNAm)
8%
Sexually Transmitted Infections
8%
Functional Outcome
8%
Fetal Growth
8%
External Beam Radiotherapy
8%
Japanese Americans
7%
Neural Tube Defects
7%
Survivors
7%
Transgender
7%
Small-for-gestational Age
7%
Primary Care
7%
High Prevalence
7%
Public Health
7%
Breast Tissue
7%
Medicaid
7%
Logistic Regression Model
7%
Testosterone
7%
Placenta
7%
HIV Epidemic
7%
Epidemiologic Studies
7%
Neighborhood Deprivation
7%
Ovarian Cancer
7%
Racial-ethnic Groups
7%
Violence
7%
Preeclampsia
7%
Obesity
7%
Birth Weight Discordance
7%
YBMSM
7%
Bisphenol A
7%
Hormone Concentration
7%
Urban Areas
7%
Mental Health
7%
Colon Cancer
7%
Randomized Controlled Trial
7%
Health-related Quality of Life
6%
Ethnic Groups
6%
Early childhood
6%
Active Surveillance
6%
HIV Transmission
6%
Male Partner
6%
Lead Exposure
6%
Healthcare Workers
6%
Endocrine Disrupting Chemicals
6%
Blood Lead
6%
Radiation Studies
6%
Human Papillomavirus Vaccine
6%
HIV-positive MSM
6%
Environmental Chemicals
6%
Sexual Risk Behavior
6%
Overall Survival
6%
Socioeconomic Disparities
6%
Trans Women
6%
Age Groups
6%
Medical Records
6%
Seroadaptation
6%
South Africa
6%
HIV Patients
6%
Cervical Cancer
6%
Cesarean Delivery
6%
Live Birth
6%
Urine Samples
6%
Patient-reported Outcomes
6%
Vancouver
6%
Radiation Therapy
6%
National Survey
6%
Twin Birth
6%
Access to Care
6%
Perinatally Acquired HIV
6%
Healthcare Utilization
6%
Multivariable Logistic Regression
6%
Cancer Screening
6%
Leptin
6%
Blood Pressure
6%
Radical Prostatectomy
6%
Retrospective Cohort Study
6%
Drug Use
6%
Cancer Mortality
6%
Disease Prevention
6%
Low-income
6%
Alcohol Use
6%
Tobago
5%
Trinidad
5%
Cluster Randomized Trial
5%
Mycoestrogens
5%
Japan
5%
Randomized Trial
5%
Low Socioeconomic Status
5%
Product Use
5%
Prostaglandin F2α
5%
Zearalenone
5%
Phthalate Mixture
5%
Fetal Mortality
5%
Cause of Death
5%
Fetus
5%
Fetal Sex
5%
Sex Partners
5%
Free Testosterone
5%
Cohort Analysis
5%
Black MSM
5%
Gestational Diabetes
5%
High-risk Population
5%
Breast Cancer Survival
5%
Hair Care Products
5%
Succimer
5%
Oxidative Stress
5%
Cancer-specific Survival
5%
Perfluorohexanoic Acid (PFHxA)
5%
Maternal Age
5%
Population Size
5%
Sampling Methods
5%
Autism Spectrum Disorder
5%
Radiotherapy
5%
Young Age
5%
Oxidative Stress Markers
5%
Exposed Infants
5%
Total Testosterone
5%
Adiponectin
5%
Fetal Growth Restriction
5%
Counseling
5%
Sexual Partners
5%
Centers for Disease Control
5%
Gestational Diabetes Mellitus
5%
Health Disparities
5%
Preschool children
5%
Collaborative Study
5%
Heart Stroke
5%
Bisexual Men
5%
Disinfection
5%
Maternal Asthma
5%
Healthcare
5%
Mortality Rate
5%
Birth Defects
5%
Gay Men
5%
Population-based Cohort
5%
Young children
5%
Adipokines
5%
Prostate
5%
Breast Tumor
5%
Pregnancy Complications
5%
Child Sex
5%
State Cancer Registry
5%
Childrens
5%
Tobacco Use
5%
Body Composition
5%
Recent Trends
5%
Sex Steroids
5%
Estrogen Receptor
5%
Personal Care Products
5%
Breast
5%
Perinatal Mortality
5%
Early Onset
5%
Low Risk
5%
Prospective Cohort Study
5%
South African children
5%
Psychosocial Stress
5%
Hospitalization
5%
Chinese Men
5%
Healthcare Professionals
5%
Health Systems
5%
Sampling Studies
5%
Vacant Lots
5%
No Significant Difference
5%
Hispanic or Latino
5%
Maputo
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Breast Cancer
59%
Men Who Have Sex with Men
53%
Prevalence
53%
Malignant Neoplasm
49%
Diseases
44%
Prostate Cancer
35%
Cohort Analysis
34%
Odds Ratio
34%
Phthalic Acid
34%
Premature Labor
30%
Urinary System
27%
Health Outcomes
24%
Child Health
21%
Metabolite
20%
Infection
20%
First Trimester Pregnancy
19%
Pregnancy
19%
Birth Weight
18%
Asthma
17%
Public Health
16%
Gestational Age
16%
Adolescence
15%
Cross Sectional Study
15%
Primary Health Care
14%
COVID-19
14%
Cancer Incidence
14%
Cohort Effect
14%
Antiretroviral Therapy
14%
Logistic Regression Analysis
14%
Neoplasm
13%
Health Care
13%
Biological Marker
13%
Cancer Registry
13%
Child Development
13%
Sex Hormone
13%
Cancer Risk
12%
Environmental Influence
12%
Quality of Life
12%
Fetus Growth
12%
Birth Outcomes
12%
Surveillance, Epidemiology, and End Results
12%
Hazard Ratio
11%
Comorbidity
11%
Prenatal Exposure
11%
Cesarean Section
11%
Radiation Therapy
11%
Stillbirth
10%
Human Immunodeficiency Virus Infection
10%
Cancer
10%
High Risk Behavior
10%
Neonatal Infant
10%
Sex Worker
9%
Case-Control Study
9%
Wart Virus
9%
Awareness
9%
Drug Use
9%
Cancer Mortality
9%
Ovarian Cancer
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
External Beam Radiotherapy
9%
HIV Test
9%
Cancer Therapy
9%
Newborn Mortality
9%
Colorectal Carcinoma
9%
Ethnic Group
9%
Socioeconomic Status
8%
Pre-Exposure Prophylaxis
8%
Low Birth Weight
8%
Cervical Cancer
8%
Body Mass Index
8%
Health Care Cost
8%
Third Trimester Pregnancy
8%
Surveillance System
8%
Diabetes
8%
Prostatectomy
7%
Mortality Rate
7%
Colon Carcinoma
7%
Counseling
7%
Small for Gestational Age
7%
Infant Mortality
7%
Cancer Survival
7%
Alcohol Consumption
7%
Retrospective Cohort Study
7%
Childhood Cancer
7%
Population Size
6%
Lung Cancer
6%
Racial Disparity
6%
Apoplexy
6%
Phthalic Acid Bis(2 Ethylhexyl) Ester
6%
Health Survey
6%
Randomized Controlled Trial
6%
Estrogen Receptor
6%
Chronic Disease
6%
Patient-Reported Outcome
6%
COVID-19 Vaccine
6%
Condom Use
6%
Gestational Diabetes
6%
Pediatrics
6%
Race Difference
6%
Cancer Screening
6%
Endocrine Disruptor
6%
Hepatitis C
6%
Placenta
6%
Maternal Welfare
6%
Obesity
5%
Diagnosis
5%
Study Participant
5%
Linear Regression Analysis
5%
Volunteer
5%
Pre-Eclampsia
5%
Fetus Mortality
5%
Androgen
5%
Cancer Diagnosis
5%
Prenatal Care
5%
DNA Methylation
5%
Proportional Hazards Model
5%
Wart Virus Vaccine
5%
Obstetrics
5%
Health Hazard
5%
Community Health
5%
Medical Record
5%
Prostate Specific Antigen
5%
Disease
5%
Harm Reduction
5%
Vaginal Delivery
5%
Breast Tumor
5%
Placenta Previa
5%
Adipocytokine
5%
Arm
5%